Skip to main content

Bain Capital Life Sciences Investors, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1703031 Boston, MA

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,333,575
+$4,915,093 QoQ
Shares Held
362,470
0.0% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
2.10%
of 13F equity value
Holder Rank
#37
of 269 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. DNTH ranks #10 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,333,575 362,470
2026-03-31 $30,418,482 362,470
2025-12-31 $30,643,426 743,592
2025-09-30 $51,780,350 1,315,892
2025-06-30 $46,244,317 2,482,250
2025-03-31 $48,791,284 2,689,707
2024-12-31 $58,635,612 2,689,707
2024-09-30 $82,507,521 3,013,423
2024-06-30 $77,987,387 3,013,423
2024-03-31 $89,760,840 2,992,028